Braden Michael Leonard - Feb 26, 2025 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
10%+ Owner
Signature
Braden Michael Leonard
Stock symbol
ADVM
Transactions as of
Feb 26, 2025
Transactions value $
$1,439,087
Form type
4
Date filed
2/28/2025, 04:04 PM
Previous filing
Oct 9, 2024
Next filing
Mar 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $661K +165K +7.27% $4.01 2.43M Feb 26, 2025 Holding of BML Investment Partners, L.P. F1, F4
transaction ADVM Common Stock Purchase $387K +86.8K +3.57% $4.46 2.52M Feb 27, 2025 Holding of BML Investment Partners, L.P. F2, F4
transaction ADVM Common Stock Purchase $391K +85.1K +3.38% $4.60 2.6M Feb 28, 2025 Holding of BML Investment Partners, L.P. F3, F4
holding ADVM Common Stock 105K Feb 26, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $4.0087 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range
F2 Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $4.4595 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
F3 Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $4.5965per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range
F4 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.